[email protected]

国际医药研究前沿

International Medical Research Frontier

您当前位置:首页 > 精选文章

International Medical Research Frontier. 2025; 9: (3) ; 10.12208/j.imrf.20250032 .

Observational study on the clinical efficacy of Niuhuang Shedan Chuanbei drop pill combined with ambroxol hydrochloride and clenbuterol hydrochloride oral solution hydrochloride and clenbuterol hydrochloride oral solution in the treatment of cough and phlegm
牛黄蛇胆川贝滴丸联合氨溴特罗止咳化痰的临床疗效观察

作者: 李龙 *

成都双流康恒中医诊所 四川成都

*通讯作者: 李龙,单位:成都双流康恒中医诊所 四川成都;

引用本文: 李龙 牛黄蛇胆川贝滴丸联合氨溴特罗止咳化痰的临床疗效观察[J]. 国际医药研究前沿, 2025; 9: (3) : 44-47.
Published: 2025/9/12 9:31:25

摘要

目的 评估牛黄蛇胆川贝滴丸联合氨溴特罗止咳化痰的临床疗效。方法 研究共纳入96例患者,将患者随机分为两组,一组为对照组,另一组为实验组。对照组口服氨溴特罗口服液治疗,而实验组则同时使用牛黄蛇胆川贝滴丸和氨溴特罗口服液进行治疗,治疗周期设定为7天。治疗前后的中医证候评估指标被用以评价临床效果,此外肺功能指标FEV1/FVC和FEV1/pred比值也被用于评估临床疗效。结果 治疗结束后,两组患者的中医证候评分及其总分都呈现出了明显的降低。其中,对照组和实验组的临床治疗总有效率分别66.7%和95.8%,经过卡方检验分析,治疗组与对照组之间存在显著差异(p<0.01)。与对照组相比,治疗组在中医证候的主症和次症方面均有显著性改善(p<0.01);肺功能指标FEV1/FVC和FEV1/pred比值也有显著性提高(p<0.05或p<0.01)。结论 牛黄蛇胆川贝滴丸联合氨溴特罗在临床上具有良好的止咳化痰疗效。

关键词: 牛黄蛇胆川贝滴丸;氨溴特罗;止咳化痰;临床评估

Abstract

Objective To evaluate the clinical efficacy of Niuhuang Shedan Chuanbei Drop Pill combined with ambroxol hydrochloride and clenbuterol hydrochloride oral solution for the treatment of cough and phlegm.
Methods A total of 96 patients were included in the study and randomly assigned to a control group and a treatment group. The control group was treated with ambroxol hydrochloride and clenbuterol hydrochloride oral solution oral solution, while the treatment group was given Niuhuang Shedan Chuanbei Drop Pill combined with ambroxol hydrochloride and clenbuterol hydrochloride oral solution oral solution for a treatment period of 7 days. Traditional Chinese medicine (TCM) syndrome evaluation indicators before and after treatment were used to assess the clinical effects. In addition, the FEV1/FVC and FEV1/pred ratios of pulmonary function were also used to evaluate the clinical efficacy.
Results After treatment, the TCM syndrome scores and their sums decreased significantly in both groups; the total clinical effective rates were 66.7% and 95.8% respectively, and the difference was statistically significant (p<0.01) by chi-square test analysis; compared to the control group, the treatment group showed significant improvements in the primary and secondary symptoms of TCM syndrome (p<0.01); the FEV1/FVC and FEV1/pred ratios of pulmonary function also significantly increased (p<0.05 or p<0.01).
Conclusion   Niuhuang Shedan Chuanbei Drop Pill combined with ambroxol hydrochloride and clenbuterol hydrochloride oral solution shows good clinical efficacy in treating cough and phlegm.

Key words: Niuhuang Shedan Chuanbei drop pill; Ambroxol hydrochloride and clenbuterol hydrochloride oral solution; Relieve cough and reduce phlegm; Clinical assessment

参考文献 References

[1] 王薇薇.分析磷酸奥司他韦治疗上呼吸道病毒感染性疾病患儿的临床效果[J].黑龙江医药,2024,37(01):108-111.

[2] 刘敬敬,程玉峰,崔磊.化痰止咳平喘汤联合布地奈德治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2024,45(02):204-207.

[3] 陈海,王建.牛黄主要活性成分及中枢系统药理作用研究进展[J].河北中医,2022,44(07):1228-1232.

[4] 刘珈含,赵维,王月等.平贝母化学成分、药理作用及临床应用研究进展[J/OL].南京中医药大学学报,2024(03): 315-328.

[5] 张林.牛黄蛇胆川贝液联合连花清瘟颗粒治疗痰热型咳嗽的临床效果[J].临床合理用药,2023,16(04):64-67.

[6] 鲁培培,刘世菊,王京奇.中医药治疗慢性咳嗽的应用现状述评[J].中外医疗,2023,42(33):194-198.

[7] 杨丽娜. 六顺汤对痰浊阻肺型老年社区获得性肺炎的疗效及相关炎症因子的影响[D].山东中医药大学,2023.

[8] 张婷,孙嵘,杨涌等.慢性阻塞性肺疾病的黏液高分泌机制及治疗[J].中国临床药理学与治疗学,2024,29(04): 383-391.

[9] 夏同霞,周芬,王玉和等.2种方案防止颈椎前路手术患者呼吸道阻塞的疗效观察[J].中国药房,2010,21(22):2091-2092.

[10] 王小川,王汉超,姚宇等.慢性阻塞性肺疾病急性加重期合并2型糖尿病患者的临床特征和危险因素分析与治疗[J].中国临床药理学与治疗学,2024,29(04):392-400.

[11] 张洁,陶裕华.肺康复训练联合综合护理干预在慢性阻塞性肺疾病合并呼吸衰竭患者中的应用效果[J].中外医学研究,2024,22(05):69-73.

[12] 尹雪燕,程玉花,谷桂芳.COPD患者延续性护理质量评价指标体系的构建[J].齐鲁护理杂志,2024,30(04):31-35.